Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa03013 | Nucleocytoplasmic transport | 68/3289 | 108/8135 | 0.00000165 | 0.0002147 | 0.0001847 | 68 | RABC94 | |
| KEGG | hsa04120 | Ubiquitin mediated proteolysis | 85/3289 | 142/8135 | 0.00000193 | 0.0002147 | 0.0001847 | 85 | RABC94 | |
| KEGG | hsa04110 | Cell cycle | 75/3289 | 126/8135 | 0.0000102 | 0.000852 | 0.0007331 | 75 | RABC94 | |
| KEGG | hsa03460 | Fanconi anemia pathway | 37/3289 | 54/8135 | 0.0000265 | 0.001768 | 0.001522 | 37 | RABC94 | |
| KEGG | hsa04144 | Endocytosis | 132/3289 | 251/8135 | 0.0000513 | 0.002856 | 0.002457 | 132 | RABC94 | |
| KEGG | hsa00900 | Terpenoid backbone biosynthesis | 18/3289 | 22/8135 | 0.0000871 | 0.004157 | 0.003577 | 18 | RABC94 | |
| KEGG | hsa00062 | Fatty acid elongation | 20/3289 | 27/8135 | 0.0004022 | 0.01679 | 0.01445 | 20 | RABC94 | |
| KEGG | hsa03050 | Proteasome | 30/3289 | 46/8135 | 0.0005768 | 0.0214 | 0.01842 | 30 | RABC94 | |
| KEGG | hsa04120 | Ubiquitin mediated proteolysis | 16/344 | 142/8135 | 0.0003107 | 0.09166 | 0.09157 | 16 | RABC95 | |
| KEGG | hsa05171 | Coronavirus disease - COVID-19 | 21/344 | 232/8135 | 0.0007928 | 0.1169 | 0.1168 | 21 | RABC95 | |
| KEGG | hsa04721 | Synaptic vesicle cycle | 20/836 | 78/8135 | 0.0000835 | 0.01695 | 0.01649 | 20 | RABC96 | |
| KEGG | hsa05323 | Rheumatoid arthritis | 22/836 | 93/8135 | 0.0001377 | 0.01695 | 0.01649 | 22 | RABC96 | |
| KEGG | hsa04110 | Cell cycle | 27/836 | 126/8135 | 0.0001536 | 0.01695 | 0.01649 | 27 | RABC96 | |
| KEGG | hsa04657 | IL-17 signaling pathway | 26/854 | 94/8135 | 0.00000243 | 0.0004659 | 0.0004119 | 26 | RABC100 | |
| KEGG | hsa04668 | TNF signaling pathway | 29/854 | 112/8135 | 0.00000282 | 0.0004659 | 0.0004119 | 29 | RABC100 | |
| KEGG | hsa04141 | Protein processing in endoplasmic reticulum | 34/854 | 171/8135 | 0.000168 | 0.01498 | 0.01324 | 34 | RABC100 | |
| KEGG | hsa00240 | Pyrimidine metabolism | 16/854 | 58/8135 | 0.000216 | 0.01498 | 0.01324 | 16 | RABC100 | |
| KEGG | hsa01240 | Biosynthesis of cofactors | 31/854 | 153/8135 | 0.0002263 | 0.01498 | 0.01324 | 31 | RABC100 | |
| KEGG | hsa04621 | NOD-like receptor signaling pathway | 35/854 | 184/8135 | 0.0003317 | 0.0183 | 0.01618 | 35 | RABC100 | |
| KEGG | hsa00513 | Various types of N-glycan biosynthesis | 12/854 | 39/8135 | 0.0004421 | 0.02091 | 0.01848 | 12 | RABC100 | |
| KEGG | hsa04622 | RIG-I-like receptor signaling pathway | 17/854 | 70/8135 | 0.0007135 | 0.02788 | 0.02465 | 17 | RABC100 | |
| KEGG | hsa05164 | Influenza A | 32/854 | 171/8135 | 0.0007883 | 0.02788 | 0.02465 | 32 | RABC100 | |
| KEGG | hsa05417 | Lipid and atherosclerosis | 38/854 | 215/8135 | 0.0008423 | 0.02788 | 0.02465 | 38 | RABC100 | |
| KEGG | hsa04064 | NF-kappa B signaling pathway | 22/854 | 104/8135 | 0.0009775 | 0.02929 | 0.02589 | 22 | RABC100 | |
| KEGG | hsa00510 | N-Glycan biosynthesis | 15/898 | 50/8144 | 0.0002102 | 0.03873 | 0.03654 | 15 | RABC126 | |
| KEGG | hsa04080 | Neuroactive ligand-receptor interaction | 62/898 | 362/8144 | 0.0002362 | 0.03873 | 0.03654 | 62 | RABC126 | |
| KEGG | hsa04660 | T cell receptor signaling pathway | 23/801 | 104/8144 | 0.0001491 | 0.04877 | 0.04804 | 23 | RABC130 | |
| KEGG | hsa05340 | Primary immunodeficiency | 11/801 | 38/8144 | 0.0007768 | 0.09323 | 0.09184 | 11 | RABC130 | |
| KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 25/801 | 131/8144 | 0.0008553 | 0.09323 | 0.09184 | 25 | RABC130 | |
| KEGG | hsa04740 | Olfactory transduction | 337/5183 | 440/8144 | 0.00000000147 | 0.00000049 | 0.000000369 | 337 | RABC134 |